Tri-City Cardiology, a Phoenix, Arizona-based cardiology group, announced on Friday that it has added Dr. Olubadewa A. Fatunde and Dr. Umashankar Lakshmanadoss to its care team.
Dr. Fatunde is joining San Tan Valley and Pecos clinics. He is board-certified in Cardiovascular Disease and Internal Medicine and is board-eligible in Cardiac Electrophysiology. Dr. Fatunde completed his internal medicine residency at the University of Texas Northeast/CHRISTUS Good Shepherd Medical Center, where he served as chief resident and chaired the Code Blue Subcommittee.
Dr. Lakshmanadoss has over a decade of experience treating patients with complex cardiac arrhythmias. He is board certified in Internal Medicine, Cardiovascular Disease, and Clinical Cardiac Electrophysiology, and is a Fellow of both the American College of Cardiology and the Heart Rhythm Society.
Tri-City Cardiology adds new members to care team
ABL Bio receives upfront payment and equity investment from Eli Lilly
Harbour BioMed and Yantai Lannacheng Biotechnology form collaboration to advance next-gen RDCs
Repare Therapeutics sells RP-3467 asset to Gilead Sciences for up to USD30m
Sanofi agrees USD2.2bn acquisition of Dynavax to strengthen adult vaccine portfolio
Sanofi and Regeneron's Dupixent gains Japan approval for paediatric asthma patients aged 6 to 11
Aqualung Therapeutics' Phase 2a lung fibrosis study approved by US FDA
Faron launches BLAZE trial with Institute of Cancer Research to address immunotherapy resistance
Alvotech launches first-in-market golimumab biosimilar in Europe
AstraZeneca secures US Breakthrough status for Enhertu in early breast cancer
GSK agrees US pricing framework to expand access to respiratory medicines
ECO Animal Health Group secures EU approval for ECOVAXXIN MS
Century Health partnerss with Tessel Biosciences to advance early drug development in COPD
Curasight reports first patient dosed in Phase 1 uTREAT trial in brain cancer